Nurix TherapeuticsInc Valuation
| NRIX Stock | USD 13.75 0.38 2.69% |
At this time, the firm appears to be undervalued. Nurix TherapeuticsInc secures a last-minute Real Value of $16.8 per share. The latest price of the firm is $13.75. Our model forecasts the value of Nurix TherapeuticsInc from analyzing the firm fundamentals such as Return On Equity of -0.65, current valuation of 479.66 M, and Profit Margin of (1.79) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Nurix TherapeuticsInc's valuation include:
Price Book 4.8758 | Enterprise Value 479.7 M | Enterprise Value Ebitda (4.25) | Price Sales 10.172 | Enterprise Value Revenue 7.516 |
Undervalued
Today
Please note that Nurix TherapeuticsInc's price fluctuation is somewhat reliable at this time. Calculation of the real value of Nurix TherapeuticsInc is based on 3 months time horizon. Increasing Nurix TherapeuticsInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nurix TherapeuticsInc is useful when determining the fair value of the Nurix stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nurix TherapeuticsInc. Since Nurix TherapeuticsInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nurix Stock. However, Nurix TherapeuticsInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.75 | Real 16.8 | Target 26.75 | Hype 12.69 | Naive 12.1 |
The real value of Nurix Stock, also known as its intrinsic value, is the underlying worth of Nurix TherapeuticsInc Company, which is reflected in its stock price. It is based on Nurix TherapeuticsInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Nurix TherapeuticsInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nurix TherapeuticsInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nurix TherapeuticsInc helps investors to forecast how Nurix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nurix TherapeuticsInc more accurately as focusing exclusively on Nurix TherapeuticsInc's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nurix TherapeuticsInc's intrinsic value based on its ongoing forecasts of Nurix TherapeuticsInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nurix TherapeuticsInc's closest peers. When choosing an evaluation method for Nurix TherapeuticsInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Nurix TherapeuticsInc Investments |
|
Nurix Valuation Trend
Knowing Nurix TherapeuticsInc's actual value is paramount for traders to make sound investment determinations. Nurix TherapeuticsInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Nurix TherapeuticsInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Nurix TherapeuticsInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Nurix Market Cap
Nurix TherapeuticsInc is regarded fourth in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 12.63 Billion. Nurix TherapeuticsInc holds roughly 862.88 Million in market capitalization claiming about 7% of equities under Health Care industry.Nurix TherapeuticsInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Nurix TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Nurix TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nurix TherapeuticsInc competition to find correlations between indicators driving Nurix TherapeuticsInc's intrinsic value. More Info.Nurix TherapeuticsInc is regarded fourth in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 2.09 of Price To Sales per Price To Book. At this time, Nurix TherapeuticsInc's Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Nurix TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nurix TherapeuticsInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nurix TherapeuticsInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nurix TherapeuticsInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nurix TherapeuticsInc and how it compares across the competition.
About Nurix TherapeuticsInc Valuation
The stock valuation mechanism determines the current worth of Nurix TherapeuticsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nurix TherapeuticsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nurix TherapeuticsInc based exclusively on its fundamental and basic technical indicators. By analyzing Nurix TherapeuticsInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nurix TherapeuticsInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nurix TherapeuticsInc. We calculate exposure to Nurix TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nurix TherapeuticsInc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 72.8 M | 76.5 M | |
| Pretax Profit Margin | (2.15) | (2.26) | |
| Operating Profit Margin | (2.32) | (2.43) | |
| Net Loss | (2.15) | (2.26) | |
| Gross Profit Margin | 0.74 | 0.78 |
8 Steps to conduct Nurix TherapeuticsInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nurix TherapeuticsInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nurix TherapeuticsInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nurix TherapeuticsInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nurix TherapeuticsInc's revenue streams: Identify Nurix TherapeuticsInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nurix TherapeuticsInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nurix TherapeuticsInc's growth potential: Evaluate Nurix TherapeuticsInc's management, business model, and growth potential.
- Determine Nurix TherapeuticsInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nurix TherapeuticsInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nurix TherapeuticsInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Nurix TherapeuticsInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 54.3 M |
Nurix TherapeuticsInc Current Valuation Indicators
Valuation refers to the process of determining the present value of Nurix TherapeuticsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nurix we look at many different elements of the entity such as Nurix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Nurix TherapeuticsInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nurix TherapeuticsInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nurix TherapeuticsInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nurix TherapeuticsInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nurix TherapeuticsInc's worth.When determining whether Nurix TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nurix TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nurix Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nurix Therapeuticsinc Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Nurix Stock analysis
When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.483 | Quarterly Revenue Growth 0.307 | Return On Assets (0.29) | Return On Equity (0.65) |
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.